178 related articles for article (PubMed ID: 31153799)
21. Early identification of peripheral neuropathy based on sudomotor dysfunction in Mexican patients with type 2 diabetes.
Carbajal-Ramírez A; Hernández-Domínguez JA; Molina-Ayala MA; Rojas-Uribe MM; Chávez-Negrete A
BMC Neurol; 2019 May; 19(1):109. PubMed ID: 31151430
[TBL] [Abstract][Full Text] [Related]
22. Peripheral neuropathy in the hands of diabetic patients with lower extremity amputations.
Pinzur MS; Labore A; Bednar M
Am J Orthop (Belle Mead NJ); 2001 Feb; 30(2):121-4. PubMed ID: 11234938
[TBL] [Abstract][Full Text] [Related]
23. Electrochemical skin conductance to detect sudomotor dysfunction, peripheral neuropathy and the risk of foot ulceration among Saudi patients with diabetes mellitus.
Sheshah E; Madanat A; Al-Greesheh F; Al-Qaisi D; Al-Harbi M; Aman R; Al-Ghamdi AA; Al-Madani K
J Diabetes Metab Disord; 2015; 15():29. PubMed ID: 27500133
[TBL] [Abstract][Full Text] [Related]
24. SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy.
Selvarajah D; Cash T; Davies J; Sankar A; Rao G; Grieg M; Pallai S; Gandhi R; Wilkinson ID; Tesfaye S
PLoS One; 2015; 10(10):e0138224. PubMed ID: 26457582
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy.
Smith AG; Lessard M; Reyna S; Doudova M; Singleton JR
J Diabetes Complications; 2014; 28(4):511-6. PubMed ID: 24661818
[TBL] [Abstract][Full Text] [Related]
26. SUDOSCAN, an Innovative, Simple and Non-Invasive Medical Device for Assessing Sudomotor Function.
Gavan DE; Gavan A; Bondor CI; Florea B; Bowling FL; Inceu GV; Colobatiu L
Sensors (Basel); 2022 Oct; 22(19):. PubMed ID: 36236669
[TBL] [Abstract][Full Text] [Related]
27. SUDOSCAN in Combination with the Michigan Neuropathy Screening Instrument Is an Effective Tool for Screening Diabetic Peripheral Neuropathy.
Oh TJ; Song Y; Jang HC; Choi SH
Diabetes Metab J; 2022 Mar; 46(2):319-326. PubMed ID: 34525791
[TBL] [Abstract][Full Text] [Related]
28. Utilizing the Ipswich Touch Test to simplify screening methods for identifying the risk of foot ulceration among diabetics: The Saudi experience.
Madanat A; Sheshah E; Badawy el-B; Abbas A; Al-Bakheet A
Prim Care Diabetes; 2015 Aug; 9(4):304-6. PubMed ID: 25466160
[TBL] [Abstract][Full Text] [Related]
29. Relationship of planter pressure and glycemic control in type 2 diabetic patients with and without neuropathy.
Halawa MR; Eid YM; El-Hilaly RA; Abdelsalam MM; Amer AH
Diabetes Metab Syndr; 2018; 12(2):99-104. PubMed ID: 28964719
[TBL] [Abstract][Full Text] [Related]
30. Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study.
Zantour B; Bouchareb S; El Ati Z; Boubaker F; Alaya W; Kossomtini W; Sfar MH
BMC Endocr Disord; 2020 Aug; 20(1):128. PubMed ID: 32831070
[TBL] [Abstract][Full Text] [Related]
31. Foot bone mass and analysis of calcium metabolism in diabetic patients affected by severe neuropathy.
Barbaro D; Orsini P; Lapi P; Turco A; Pasquini C
Minerva Endocrinol; 2008 Dec; 33(4):283-8. PubMed ID: 18923365
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of factors associated with extremity ulceration in diabetic subjects with peripheral neuropathy].
Porciúncula MV; Rolim LC; Garofolo L; Ferreira SR
Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1134-42. PubMed ID: 18157390
[TBL] [Abstract][Full Text] [Related]
33. Assessment of sensory neuropathy in diabetic patients without diabetic foot problems.
Nather A; Neo SH; Chionh SB; Liew SC; Sim EY; Chew JL
J Diabetes Complications; 2008; 22(2):126-31. PubMed ID: 18280443
[TBL] [Abstract][Full Text] [Related]
34. Electrochemical skin conductances values and clinical factors affecting sudomotor dysfunction in patients with prediabetes, type 1 diabetes, and type 2 diabetes: A single center experience.
Calikoglu BF; Celik S; Idiz C; Bagdemir E; Issever H; Calvet JH; Satman I
Prim Care Diabetes; 2023 Oct; 17(5):499-505. PubMed ID: 37394312
[TBL] [Abstract][Full Text] [Related]
35. Assessment of small fiber neuropathy through a quick, simple and non invasive method in a German diabetes outpatient clinic.
Calvet JH; Dupin J; Winiecki H; Schwarz PE
Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):80-3. PubMed ID: 23073917
[TBL] [Abstract][Full Text] [Related]
36. The relationship between sudomotor function and skin microvascular reactivity in individuals with type 1 diabetes of long duration.
Gandecka A; Araszkiewicz A; Piłaciński S; Wierusz-Wysocka B; Zozulińska-Ziółkiewicz D
Microvasc Res; 2018 Nov; 120():84-89. PubMed ID: 30044961
[TBL] [Abstract][Full Text] [Related]
37. Plantar pressure distribution in Type 2 diabetic patients without peripheral neuropathy and peripheral vascular disease.
Pataky Z; Assal JP; Conne P; Vuagnat H; Golay A
Diabet Med; 2005 Jun; 22(6):762-7. PubMed ID: 15910629
[TBL] [Abstract][Full Text] [Related]
38. The potential impact and diagnostic value of inflammatory markers on diabetic foot progression in type II diabetes mellitus: A case-control study.
Mohamed AA; Elmotaleb Hussein MA; Nabil Hanna I; Japer Nashwan AJ; Saleh M; Abdel Wahed WY; Mohamed Mansour AM; Ezz Al Arab MR; Fawzy N; Sakr Y; Shalby H; AlHussain E; Kamal Darwish M; El-Osaily H; Naguib M; Mohamed AA; Farouk Mohamed W; Hafez W
Med Clin (Barc); 2024 May; 162(9):e33-e39. PubMed ID: 38458959
[TBL] [Abstract][Full Text] [Related]
39. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
40. The utility of Vibratip in accurate identification of loss of protective sensation in the contralateral foot of patients admitted with a diabetic foot ulcer.
Pasangha E; George B; Jayalakshmi V; Devi P; Ayyar V; Bantwal G
Diabetes Metab Syndr; 2021; 15(3):857-862. PubMed ID: 33873055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
